{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:36:57Z","timestamp":1792784217643,"version":"4.5.0"},"reference-count":214,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Excellence Departments, MIUR-Italy","award":["ARTICOLO 1"],"award-info":[{"award-number":["ARTICOLO 1"]}]},{"name":"Excellence Departments, MIUR-Italy","award":["COMMI 314\u2013337"],"award-info":[{"award-number":["COMMI 314\u2013337"]}]},{"name":"Excellence Departments, MIUR-Italy","award":["LEGGE 232\/2016"],"award-info":[{"award-number":["LEGGE 232\/2016"]}]},{"name":"Excellence Departments, MIUR-Italy","award":["ARTICOLO 1"],"award-info":[{"award-number":["ARTICOLO 1"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.neuropharm.2018.12.024","type":"journal-article","created":{"date-parts":[[2019,1,9]],"date-time":"2019-01-09T11:06:46Z","timestamp":1547032006000},"page":"107477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder"],"prefix":"10.1016","volume":"159","author":[{"given":"Anna Maria","family":"Tartaglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Schiavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Calamandrei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3922-6045","authenticated-orcid":false,"given":"Viviana","family":"Trezza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.12.024_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1136\/jnnp.2003.029132","article-title":"The longer term outcome of children born to mothers with epilepsy","volume":"75","author":"Adab","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000362645","article-title":"The ketogenic diet modifies social and metabolic alterations identified in the prenatal valproic acid model of autism spectrum disorder","volume":"36","author":"Ahn","year":"2014","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0304-3940(00)01457-9","article-title":"Vitamin E decreases valproic acid induced neural tube defects in mice","volume":"292","author":"Al Deeb","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.bbr.2015.02.041","article-title":"Astaxanthin improves behavioral disorder and oxidative stress in prenatal valproic acid-induced mice model of autism","volume":"286","author":"Al-Amin","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/6338","article-title":"Activation of NMDA receptors reverses desensitization of mGluR5 in native and recombinant systems","volume":"2","author":"Alagarsamy","year":"1999","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/j.1365-2125.1984.tb02414.x","article-title":"Differential transplacental binding of valproic acid: influence of free fatty acids","volume":"17","author":"Albani","year":"1984","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib7","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1517\/14740338.4.2.345","article-title":"Teratogenicity of sodium valproate","volume":"4","author":"Alsdorf","year":"2005","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/13810","article-title":"Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2","volume":"23","author":"Amir","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib9","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.biopsych.2006.02.032","article-title":"Effects of short- and long-term risperidone treatment on prolactin levels in children with autism","volume":"61","author":"Anderson","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib10","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/s41467-017-00868-y","article-title":"Cross-tissue integration of genetic and epigenetic data offers insight into autism spectrum disorder","volume":"8","author":"Andrews","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib11","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1002\/aur.1852","article-title":"Altered attentional processing in male and female rats in a prenatal valproic acid exposure model of autism spectrum disorder","volume":"10","author":"Anshu","year":"2017","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib12","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ajmg.1320290123","article-title":"Verification of the fetal valproate syndrome phenotype","volume":"29","author":"Ardinger","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib13","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3389\/fnhum.2013.00417","article-title":"Studying autism in rodent models: reconciling endophenotypes with comorbidities","volume":"7","author":"Argyropoulos","year":"2013","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib14","article-title":"Valproate prescribing in women of childbearing age: an audit of clinical practice","volume":"6","author":"Atturu","year":"2015","journal-title":"Advances in Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib15","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1212\/WNL.0000000000001182","article-title":"IQ at 6 years after in utero exposure to antiepileptic drugs: a controlled cohort study","volume":"84","author":"Baker","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048831","article-title":"HERVs expression in Autism Spectrum Disorders","volume":"7","author":"Balestrieri","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/15622975.2013.862345","article-title":"Human endogenous retroviruses and ADHD","volume":"15","author":"Balestrieri","year":"2014","journal-title":"World J. Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib18","first-page":"228","article-title":"Transcriptional activity of human endogenous retrovirus in Albanian children with autism spectrum disorders","volume":"39","author":"Balestrieri","year":"2016","journal-title":"New Microbiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib19","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.neulet.2014.09.039","article-title":"Resveratrol prevents social deficits in animal model of autism induced by valproic acid","volume":"583","author":"Bambini-Junior","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib20","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116363","article-title":"Effects of an H3R antagonist on the animal model of autism induced by prenatal exposure to valproic acid","volume":"10","author":"Baronio","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-1211(02)00237-1","article-title":"Epilepsy and pregnancy: report of an epilepsy research foundation workshop","volume":"52","author":"Barrett","year":"2003","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib23","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13229-017-0160-x","article-title":"Developmental disruption of amygdala transcriptome and socioemotional behavior in rats exposed to valproic acid prenatally","volume":"8","author":"Barrett","year":"2017","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00213-006-0578-x","article-title":"The debate over dopamine's role in reward: the case for incentive salience","volume":"191","author":"Berridge","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/FBP.0000000000000316","article-title":"Suppressed play behaviour and decreased oxytocin receptor binding in the amygdala after prenatal exposure to low-dose valproic acid","volume":"28","author":"Bertelsen","year":"2017","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/nprot.2017.050","article-title":"Assessing recent and remote associative olfactory memory in rats using the social transmission of food preference paradigm","volume":"12","author":"Bessieres","year":"2017","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0149-7634(05)80031-4","article-title":"On the significance of similarities between ultrasonic vocalizations of infant and adult rats","volume":"15","author":"Blumberg","year":"1991","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib28","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/ejn.13595","article-title":"Neurobiological bases of autism-epilepsy comorbidity: a focus on excitation\/inhibition imbalance","volume":"47","author":"Bozzi","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib29","article-title":"Analysis of ultrasonic vocalizations emitted by infant rodents","volume":"13","author":"Branchi","year":"2006","journal-title":"Curr Protoc Toxicol Chapter"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib30","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.wnl.0000339399.64213.1a","article-title":"Autism spectrum disorders following in utero exposure to antiepileptic drugs","volume":"71","author":"Bromley","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/jnnp-2012-304270","article-title":"The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs","volume":"84","author":"Bromley","year":"2013","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib32","article-title":"Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child","author":"Bromley","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib33","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2174\/1570159X13999150210141444","article-title":"Pharmacology of ultrasonic vocalizations in adult rats: significance, call classification and neural substrate","volume":"13","author":"Brudzynski","year":"2015","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib34","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1089\/cap.2010.0121","article-title":"An open label trial of donepezil for enhancement of rapid eye movement sleep in young children with autism spectrum disorders","volume":"21","author":"Buckley","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fnbeh.2012.00073","article-title":"The endocannabinoid system: a key modulator of emotions and cognition","volume":"6","author":"Campolongo","year":"2012","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13229-018-0221-9","article-title":"Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment","volume":"9","author":"Campolongo","year":"2018","journal-title":"Mol. Autism."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neuroscience.2017.12.053","article-title":"Altered brain cholesterol\/isoprenoid metabolism in a rat model of autism spectrum disorders","volume":"372","author":"Cartocci","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.pnpbp.2018.02.008","article-title":"Zinc as a therapy in a rat model of autism prenatally induced by valproic acid","volume":"84","author":"Cezar","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib39","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/BF02968255","article-title":"Antioxidant and neuroprotective effects of hesperidin and its aglycone hesperetin","volume":"29","author":"Cho","year":"2006","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib40","doi-asserted-by":"crossref","first-page":"36250","DOI":"10.1038\/srep36250","article-title":"The transgenerational inheritance of autism-like phenotypes in mice exposed to valproic acid during pregnancy","volume":"6","author":"Choi","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib41","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2202-11-102","article-title":"Altering the trajectory of early postnatal cortical development can lead to structural and behavioural features of autism","volume":"11","author":"Chomiak","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib42","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1001\/jama.2013.2270","article-title":"Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism","volume":"309","author":"Christensen","year":"2013","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib43","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1469-8749.1994.tb11858.x","article-title":"Fetal valproate syndrome: clinical and neuro-developmental features in two sibling pairs","volume":"36","author":"Christianson","year":"1994","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41598-017-19035-w","article-title":"High expression of Endogenous Retroviruses from intrauterine life to adulthood in two mouse models of Autism Spectrum Disorders","volume":"8","author":"Cipriani","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib45","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1136\/jmg.32.9.724","article-title":"Fetal valproate syndrome","volume":"32","author":"Clayton-Smith","year":"1995","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.biopsych.2018.06.014","article-title":"Programming bugs: microbiota and the developmental origins of brain health and disease","volume":"85","author":"Codagnone","year":"2019","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib47","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/mrdd.20039","article-title":"Designing mouse behavioral tasks relevant to autistic-like behaviors","volume":"10","author":"Crawley","year":"2004","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.neubiorev.2018.07.011","article-title":"The role of epigenetic modifications in neurodevelopmental disorders: a systematic review","volume":"94","author":"Dall'Aglio","year":"2018","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib49","doi-asserted-by":"crossref","first-page":"12560","DOI":"10.1073\/pnas.0506071102","article-title":"Reduced cortical activity due to a shift in the balance between excitation and inhibition in a mouse model of Rett syndrome","volume":"102","author":"Dani","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib50","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.bbi.2013.12.005","article-title":"Altered gut microbiota and activity in a murine model of autism spectrum disorders","volume":"37","author":"de Theije","year":"2014","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib51","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2165\/11632000-000000000-00000","article-title":"Minocycline: therapeutic potential in psychiatry","volume":"26","author":"Dean","year":"2012","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib52","series-title":"Neuroimmune Alterations in Autism: A Translational Analysis Focusing on the Animal Model of Autism Induced by Prenatal Exposure to Valproic Acid","first-page":"1","author":"Deckmann","year":"2018"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib54","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/ajmg.1320190308","article-title":"The fetal valproate syndrome","volume":"19","author":"DiLiberti","year":"1984","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib55","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1080\/17470919.2015.1087875","article-title":"Autism: oxytocin, serotonin, and social reward","volume":"10","author":"Dolen","year":"2015","journal-title":"Soc. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010103","article-title":"Free radical scavenging and cellular antioxidant properties of astaxanthin","volume":"17","author":"Dose","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.conb.2015.12.009","article-title":"The contribution of ultrasonic vocalizations to mouse courtship","volume":"38","author":"Egnor","year":"2016","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib58","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1038\/s41598-018-31385-7","article-title":"The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism","volume":"8","author":"Eissa","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib59","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3389\/fncel.2018.00256","article-title":"Early disruption of the microbiome leading to decreased antioxidant capacity and epigenetic changes: implications for the rise in autism","volume":"12","author":"Eshraghi","year":"2018","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib60","first-page":"1","article-title":"Sex\/gender differences in screening for autism spectrum disorder: implications for evidence-based assessment","author":"Evans","year":"2018","journal-title":"J. Clin. Child Adolesc. Psychol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib61","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1523\/JNEUROSCI.21-20-08278.2001","article-title":"Oxytocin in the medial amygdala is essential for social recognition in the mouse","volume":"21","author":"Ferguson","year":"2001","journal-title":"J. Neurosci."},{"issue":"Suppl. 2","key":"10.1016\/j.neuropharm.2018.12.024_bib62","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.mp.4001162","article-title":"Epidemiological trends in rates of autism","volume":"7","author":"Fombonne","year":"2002","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib63","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fnsyn.2018.00009","article-title":"Resveratrol prevents cellular and behavioral sensory alterations in the animal model of autism induced by valproic acid","volume":"10","author":"Fontes-Dutra","year":"2018","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib64","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib65","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.yebeh.2018.01.002","article-title":"Women with epilepsy in childbearing age: pregnancy-related knowledge, information sources, and antiepileptic drugs","volume":"80","author":"Friedrich","year":"2018","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib66","doi-asserted-by":"crossref","first-page":"10908","DOI":"10.1523\/JNEUROSCI.0229-16.2016","article-title":"In utero exposure to valproic acid induces neocortical dysgenesis via dysregulation of neural progenitor cell proliferation\/differentiation","volume":"36","author":"Fujimura","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib67","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","article-title":"Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions","volume":"65","author":"Fukuchi","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib68","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.biopsych.2010.09.031","article-title":"Validating gamma oscillations and delayed auditory responses as translational biomarkers of autism","volume":"68","author":"Gandal","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib69","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ijdevneu.2015.11.006","article-title":"Neuroprotective effects of docosahexaenoic acid on hippocampal cell death and learning and memory impairments in a valproic acid-induced rat autism model","volume":"49","author":"Gao","year":"2016","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib70","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jnutbio.2016.07.003","article-title":"Maternal DHA supplementation protects rat offspring against impairment of learning and memory following prenatal exposure to valproic acid","volume":"35","author":"Gao","year":"2016","journal-title":"J. Nutr. Biochem."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bph.12139","article-title":"Minocycline: far beyond an antibiotic","volume":"169","author":"Garrido-Mesa","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib72","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1362361301005003005","article-title":"Anxiety in high-functioning children with autism","volume":"5","author":"Gillott","year":"2001","journal-title":"Autism"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib73","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.neuropharm.2012.07.028","article-title":"Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3beta\/beta-catenin pathway","volume":"63","author":"Go","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib74","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1177\/0269881109102919","article-title":"Evidence-based guidelines for treating bipolar disorder: revised second edition--recommendations from the British Association for Psychopharmacology","volume":"23","author":"Goodwin","year":"2009","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib75","doi-asserted-by":"crossref","first-page":"527","DOI":"10.4088\/JCP.15m10046","article-title":"Guideline adherence for mentally ill reproductive-aged women on treatment with valproic acid: a retrospective chart review","volume":"77","author":"Gotlib","year":"2016","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib76","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11920-017-0809-3","article-title":"Valproic acid in women and girls of childbearing age","volume":"19","author":"Gotlib","year":"2017","journal-title":"Curr. Psychiatr. Rep."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib77","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s11689-018-9228-y","article-title":"The effects of intranasal oxytocin on reward circuitry responses in children with autism spectrum disorder","volume":"10","author":"Greene","year":"2018","journal-title":"J. Neurodev. Disord."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib78","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1089\/cap.2010.0024","article-title":"Safety and efficacy of donepezil in children and adolescents with autism: neuropsychological measures","volume":"21","author":"Handen","year":"2011","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.bbr.2015.04.022","article-title":"Reduced prefrontal dopaminergic activity in valproic acid-treated mouse autism model","volume":"289","author":"Hara","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib80","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/aur.1596","article-title":"Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism","volume":"9","author":"Hara","year":"2016","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib81","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.yhbeh.2017.09.013","article-title":"Oxytocin attenuates deficits in social interaction but not recognition memory in a prenatal valproic acid-induced mouse model of autism","volume":"96","author":"Hara","year":"2017","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib82","doi-asserted-by":"crossref","first-page":"3217","DOI":"10.1007\/s00213-017-4703-9","article-title":"Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice","volume":"234","author":"Hara","year":"2017","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib83","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1528-1167.2009.02129.x","volume":"50","author":"Harden","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib84","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.cyto.2014.10.027","article-title":"Interplay between pro-inflammatory cytokines and brain oxidative stress biomarkers: evidence of parallels between butyl paraben intoxication and the valproic acid brain physiopathology in autism rat model","volume":"71","author":"Hegazy","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib85","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.fct.2018.02.061","article-title":"Behavioral alterations in autism model induced by valproic acid and translational analysis of circulating microRNA","volume":"115","author":"Hirsch","year":"2018","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib86","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.2044-835X.2012.02083.x","article-title":"The relation between social engagement and pretend play in autism","volume":"31","author":"Hobson","year":"2013","journal-title":"Br. J. Dev. Psychol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib87","doi-asserted-by":"crossref","first-page":"174","DOI":"10.4306\/pi.2016.13.2.174","article-title":"Plasma oxytocin in children with autism and its correlations with behavioral parameters in children and parents","volume":"13","author":"Husarova","year":"2016","journal-title":"Psychiatry Investig"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib88","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.neuron.2010.03.005","article-title":"The challenge of translation in social neuroscience: a review of oxytocin, vasopressin, and affiliative behavior","volume":"65","author":"Insel","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib89","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0006-3223(98)00142-5","article-title":"Oxytocin, vasopressin, and autism: is there a connection?","volume":"45","author":"Insel","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib300","series-title":"Enqu\u00eate relative aux sp\u00e9cialit\u00e9s pharmaceutiques contenant du valproate de sodium. France","author":"Inspection g\u00e9n\u00e9rale des affaires sociales (IGAS)","year":"2016"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib90","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/1362361303007004002","article-title":"Social play and autistic spectrum disorders: a perspective on theory, implications and educational approaches","volume":"7","author":"Jordan","year":"2003","journal-title":"Autism"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib91","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.stemcr.2015.10.012","article-title":"Reduced adult hippocampal neurogenesis and cognitive impairments following prenatal treatment of the antiepileptic drug valproic acid","volume":"5","author":"Juliandi","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib92","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fnmol.2015.00017","article-title":"Suppression of NMDA receptor function in mice prenatally exposed to valproic acid improves social deficits and repetitive behaviors","volume":"8","author":"Kang","year":"2015","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib93","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1017\/S1355617707070804","article-title":"Neuropsychological outcomes in children of mothers with epilepsy","volume":"13","author":"Kantola-Sorsa","year":"2007","journal-title":"J. Int. Neuropsychol. Soc."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib94","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145711001714","article-title":"Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid","volume":"16","author":"Kataoka","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psyneuen.2016.06.001","article-title":"Postnatal behavioral and inflammatory alterations in female pups prenatally exposed to valproic acid","volume":"72","author":"Kazlauskas","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib97","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fnins.2017.00490","article-title":"Cross talk: the microbiota and neurodevelopmental disorders","volume":"11","author":"Kelly","year":"2017","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bbr.2013.04.043","article-title":"Alterations in the endocannabinoid system in the rat valproic acid model of autism","volume":"249","author":"Kerr","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib99","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phrs.2016.08.033","article-title":"Pharmacological inhibition of fatty acid amide hydrolase attenuates social behavioural deficits in male rats prenatally exposed to valproic acid","volume":"113","author":"Kerr","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib100","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ijdevneu.2018.06.009","article-title":"Hesperetin and it nanocrystals ameliorate social behavior deficits and oxido-inflammatory stress in rat model of autism","volume":"69","author":"Khalaj","year":"2018","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib101","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.toxlet.2010.12.018","article-title":"The critical period of valproate exposure to induce autistic symptoms in Sprague-Dawley rats","volume":"201","author":"Kim","year":"2011","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib102","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/jnc.12147","article-title":"Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder","volume":"124","author":"Kim","year":"2013","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib103","doi-asserted-by":"crossref","first-page":"e104927","DOI":"10.1371\/journal.pone.0104927","article-title":"Subchronic treatment of donepezil rescues impaired social, hyperactive, and stereotypic behavior in valproic acid-induced animal model of autism","volume":"9","author":"Kim","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib104","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s12035-013-8535-2","article-title":"Pax6-dependent cortical glutamatergic neuronal differentiation regulates autism-like behavior in prenatally valproic acid-exposed rat offspring","volume":"49","author":"Kim","year":"2014","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib105","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12035-014-8987-z","article-title":"MeCP2 modulates sex differences in the postsynaptic development of the valproate animal model of autism","volume":"53","author":"Kim","year":"2016","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib106","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2016.09.014","article-title":"Agmatine rescues autistic behaviors in the valproic acid-induced animal model of autism","volume":"113","author":"Kim","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib107","first-page":"1","article-title":"Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism","volume":"0","author":"Kim","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib108","doi-asserted-by":"crossref","first-page":"F90","DOI":"10.1136\/adc.2004.067421","article-title":"Dysmorphic features: an important clue to the diagnosis and severity of fetal anticonvulsant syndromes","volume":"91","author":"Kini","year":"2006","journal-title":"Arch Dis Child Fetal Neonatal"},{"issue":"6","key":"10.1016\/j.neuropharm.2018.12.024_bib109","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1159\/000481134","article-title":"Sexually dimorphic epigenetic regulation of brain-derived neurotrophic factor in fetal brain in the valproic acid model of autism spectrum disorder","volume":"39","author":"Konopko","year":"2017","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib110","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.seizure.2011.06.012","article-title":"Antiepileptic drug use during pregnancy: perinatal outcomes","volume":"20","author":"Kulaga","year":"2011","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib111","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainresbull.2016.03.013","article-title":"Memantine ameliorates autistic behavior, biochemistry & blood brain barrier impairments in rats","volume":"124","author":"Kumar","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib112","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2015.10.052","article-title":"Minocycline ameliorates prenatal valproic acid induced autistic behaviour, biochemistry and blood brain barrier impairments in rats","volume":"1630","author":"Kumar","year":"2016","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib113","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ridd.2005.03.003","article-title":"Neurochemical correlates of autistic disorder: a review of the literature","volume":"27","author":"Lam","year":"2006","journal-title":"Res. Dev. Disabil."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib114","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1471-244X-13-234","article-title":"Teratogenic risk and contraceptive counselling in psychiatric practice: analysis of anticonvulsant therapy","volume":"13","author":"Langan","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/jhg.2013.49","article-title":"Epigenomic strategies at the interface of genetic and environmental risk factors for autism","volume":"58","author":"LaSalle","year":"2013","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib116","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10803-006-0123-0","article-title":"Comorbid psychiatric disorders in children with autism: interview development and rates of disorders","volume":"36","author":"Leyfer","year":"2006","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib117","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fncel.2017.00120","article-title":"The gut microbiota and autism spectrum disorders","volume":"11","author":"Li","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib118","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13041-017-0292-0","article-title":"Modeling environmental risk factors of autism in mice induces IBD-related gut microbial dysbiosis and hyperserotonemia","volume":"10","author":"Lim","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib119","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0306-9877(97)90032-3","article-title":"Oral famotidine: a potential treatment for children with autism","volume":"48","author":"Linday","year":"1997","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib120","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fneur.2015.00107","article-title":"The role of epigenetic change in autism spectrum disorders","volume":"6","author":"Loke","year":"2015","journal-title":"Front. Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib121","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jaac.2017.03.013","article-title":"What is the male-to-female ratio in autism spectrum disorder? A systematic review and meta-analysis","volume":"56","author":"Loomes","year":"2017","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib122","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/aur.1338","article-title":"Altered peripheral and central inflammatory responses in a mouse model of autism","volume":"7","author":"Lucchina","year":"2014","journal-title":"Autism Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib123","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1186\/s12884-018-1842-x","article-title":"Sodium valproate in pregnancy: what are the risks and should we use a shared decision-making approach?","volume":"18","author":"Macfarlane","year":"2018","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib124","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/jcpp.12913","article-title":"The development of autistic social traits across childhood and adolescence in males and females","volume":"59","author":"Mandy","year":"2018","journal-title":"JCPP (J. Child Psychol. Psychiatry)"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib125","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","article-title":"A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder","volume":"48","author":"Marcus","year":"2009","journal-title":"J. Am. Acad. Child Adolesc. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib126","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/sj.npp.1301453","article-title":"Abnormal fear conditioning and amygdala processing in an animal model of autism","volume":"33","author":"Markram","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib127","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S1059-1311(02)00135-8","article-title":"Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate","volume":"11","author":"Mawer","year":"2002","journal-title":"Seizure"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib128","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","article-title":"Risperidone in children with autism and serious behavioral problems","volume":"347","author":"McCracken","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib129","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1535-7511.2008.00273.x","article-title":"Effects of in utero antiepileptic drug exposure","volume":"8","author":"Meador","year":"2008","journal-title":"Epilepsy Curr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib130","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S1474-4422(12)70323-X","article-title":"Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study","volume":"12","author":"Meador","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib131","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026077","article-title":"mGluR5-antagonist mediated reversal of elevated stereotyped, repetitive behaviors in the VPA model of autism","volume":"6","author":"Mehta","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib132","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/bph.14435","article-title":"Sex-specific autistic endophenotypes induced by prenatal exposure to valproic acid involve anandamide signalling","volume":"175","author":"Melancia","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib133","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/dev.20130","article-title":"Maternal and littermate deprivation disrupts maternal behavior and social-learning of food preference in adulthood: tactile stimulation, nest odor, and social rearing prevent these effects","volume":"48","author":"Melo","year":"2006","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib134","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/841749","article-title":"The importance of antioxidant micronutrients in pregnancy","volume":"2011","author":"Mistry","year":"2011","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib135","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2215-0366(14)70314-1","article-title":"Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis","volume":"1","author":"Miura","year":"2014","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib136","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ijdevneu.2004.05.004","article-title":"Maternal administration of thalidomide or valproic acid causes abnormal serotonergic neurons in the offspring: implication for pathogenesis of autism","volume":"23","author":"Miyazaki","year":"2005","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib137","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.bbr.2013.09.049","article-title":"Inhibition of histone deacetylase in utero causes sociability deficits in postnatal mice","volume":"257","author":"Moldrich","year":"2013","journal-title":"Behav. Brain Res."},{"issue":"Suppl. 6","key":"10.1016\/j.neuropharm.2018.12.024_bib138","first-page":"9","article-title":"Treatment of bipolar disorder","volume":"64","author":"Moller","year":"2003","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib139","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib140","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1601-1848.2004.00076.x","article-title":"Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice","volume":"3","author":"Moy","year":"2004","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib141","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bbr.2008.03.015","article-title":"Social approach and repetitive behavior in eleven inbred mouse strains","volume":"191","author":"Moy","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib142","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1159\/000341786","article-title":"Effects of rat prenatal exposure to valproic acid on behaviour and neuro-anatomy","volume":"34","author":"Mychasiuk","year":"2012","journal-title":"Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib143","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1212\/WNL.0b013e31820d62c7","article-title":"Language skills of school-aged children prenatally exposed to antiepileptic drugs","volume":"76","author":"Nadebaum","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib144","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.celrep.2017.01.006","article-title":"Abnormal development of the earliest cortical circuits in a mouse model of autism spectrum disorder","volume":"18","author":"Nagode","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib145","first-page":"576","article-title":"Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism","volume":"52","author":"Narita","year":"2002","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib146","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2165\/00003088-198207060-00003","article-title":"Anticonvulsants during pregnancy and lactation. Transplacental, maternal and neonatal pharmacokinetics","volume":"7","author":"Nau","year":"1982","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib147","first-page":"CD011412","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"12","author":"Nevitt","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib148","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.expneurol.2017.04.017","article-title":"The valproic acid-induced rodent model of autism","volume":"299","author":"Nicolini","year":"2018","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib149","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.reprotox.2006.03.014","article-title":"Neuroteratogens in man: an overview with special emphasis on the teratogenicity of antiepileptic drugs in pregnancy","volume":"22","author":"Ornoy","year":"2006","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","article-title":"Valproic acid in pregnancy: how much are we endangering the embryo and fetus?","volume":"28","author":"Ornoy","year":"2009","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib151","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","article-title":"Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder","volume":"124","author":"Owen","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib152","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0149-7634(84)90005-8","article-title":"The psychobiology of play: theoretical and methodological perspectives","volume":"8","author":"Panksepp","year":"1984","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib153","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ijdevneu.2016.07.001","article-title":"Prenatal exposure to sodium valproate alters androgen receptor expression in the developing cerebellum in a region and age specific manner in male and female rats","volume":"53","author":"Perez-Pouchoulen","year":"2016","journal-title":"Int. J. Dev. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib154","doi-asserted-by":"crossref","DOI":"10.3390\/antiox7050063","article-title":"Anti-oxidant and anti-inflammatory activity of ketogenic diet: new perspectives for neuroprotection in alzheimer's disease","volume":"7","author":"Pinto","year":"2018","journal-title":"Antioxidants"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib155","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.yhbeh.2011.10.010","article-title":"Oxytocin receptor knockout mice display deficits in the expression of autism-related behaviors","volume":"61","author":"Pobbe","year":"2012","journal-title":"Horm. Behav."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib156","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/archpsyc.1991.01810250064008","article-title":"Valproate in the treatment of acute mania. A placebo-controlled study","volume":"48","author":"Pope","year":"1991","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib157","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1017\/S0012162205001076","article-title":"Characteristics of fetal anticonvulsant syndrome associated autistic disorder","volume":"47","author":"Rasalam","year":"2005","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib158","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/FBP.0000000000000169","article-title":"Effects of prenatal exposure to valproic acid on the development of juvenile-typical social play in rats","volume":"26","author":"Raza","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib159","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.bbr.2006.08.024","article-title":"Behavioral phenotyping of mouse models of neurodevelopmental disorders: relevant social behavior patterns across the life span","volume":"176","author":"Ricceri","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib160","doi-asserted-by":"crossref","first-page":"13501","DOI":"10.1073\/pnas.0704391104","article-title":"Elevated NMDA receptor levels and enhanced postsynaptic long-term potentiation induced by prenatal exposure to valproic acid","volume":"104","author":"Rinaldi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib161","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3389\/neuro.04.004.2008","article-title":"Hyper-connectivity and hyper-plasticity in the medial prefrontal cortex in the valproic Acid animal model of autism","volume":"2","author":"Rinaldi","year":"2008","journal-title":"Front. Neural Circuits"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib162","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1093\/cercor\/bhm117","article-title":"Hyperconnectivity of local neocortical microcircuitry induced by prenatal exposure to valproic acid","volume":"18","author":"Rinaldi","year":"2008","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib163","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.2014.13101359","article-title":"Familial recurrence of autism spectrum disorder: evaluating genetic and environmental contributions","volume":"171","author":"Risch","year":"2014","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib164","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","article-title":"Maternal valproic acid and congenital neural tube defects","volume":"2","author":"Robert","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib165","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/mp.2016.50","article-title":"From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways","volume":"21","author":"Rogers","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib166","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/088307389901400814","article-title":"Niaprazine in the treatment of autistic disorder","volume":"14","author":"Rossi","year":"1999","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib167","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.neuroscience.2010.06.069","article-title":"Behavioral and molecular changes in the mouse in response to prenatal exposure to the anti-epileptic drug valproic acid","volume":"170","author":"Roullet","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib168","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ntt.2013.01.004","article-title":"In utero exposure to valproic acid and autism--a current review of clinical and animal studies","volume":"36","author":"Roullet","year":"2013","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib169","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1034\/j.1601-183X.2003.00037.x","article-title":"Model of autism: increased ratio of excitation\/inhibition in key neural systems","volume":"2","author":"Rubenstein","year":"2003","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib170","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1007\/s10803-006-0240-9","article-title":"A longitudinal study of pretend play in autism","volume":"37","author":"Rutherford","year":"2007","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib171","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.neulet.2014.07.036","article-title":"Long-term valproic acid exposure increases the number of neocortical neurons in the developing rat brain. A possible new animal model of autism","volume":"580","author":"Sabers","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib172","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","article-title":"The mysterious motivational functions of mesolimbic dopamine","volume":"76","author":"Salamone","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib173","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neubiorev.2008.08.003","article-title":"Ultrasonic vocalizations: a tool for behavioural phenotyping of mouse models of neurodevelopmental disorders","volume":"33","author":"Scattoni","year":"2009","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib174","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.npp.1300518","article-title":"Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism","volume":"30","author":"Schneider","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib175","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.npp.1300767","article-title":"Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism","volume":"31","author":"Schneider","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib176","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00213-007-0795-y","article-title":"Prenatal exposure to valproic acid disturbs the enkephalinergic system functioning, basal hedonic tone, and emotional responses in an animal model of autism","volume":"193","author":"Schneider","year":"2007","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib177","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.psyneuen.2008.02.011","article-title":"Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid","volume":"33","author":"Schneider","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib178","doi-asserted-by":"crossref","first-page":"e902","DOI":"10.1038\/tp.2016.182","article-title":"Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid","volume":"6","author":"Servadio","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib179","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.euroneuro.2017.11.014","article-title":"Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid","volume":"28","author":"Servadio","year":"2018","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib180","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","article-title":"Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders","volume":"114","author":"Shea","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib181","first-page":"1","article-title":"Enhanced long-term microcircuit plasticity in the valproic Acid animal model of autism","volume":"1","author":"Silva","year":"2009","journal-title":"Front. Synaptic Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib182","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ntt.2006.08.004","article-title":"Induction of the homeotic gene Hoxa1 through valproic acid's teratogenic mechanism of action","volume":"28","author":"Stodgell","year":"2006","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib183","first-page":"2795","article-title":"Deficits in mesolimbic reward pathway underlie social interaction impairments in children with autism","volume":"141","author":"Supekar","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib184","article-title":"Early behavioral alterations and increased expression of endogenous retroviruses are inherited across generations in mice prenatally exposed to valproic acid","author":"Tartaglione","year":"2018","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1002\/(SICI)1098-2302(199605)29:4<353::AID-DEV4>3.0.CO;2-P","article-title":"Effects of altered olfactory experiences on the development of infant rats' responses to odors","volume":"29","author":"Terry","year":"1996","journal-title":"Dev. Psychobiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib186","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.1111\/epi.13437","article-title":"Withdrawal of valproic acid treatment during pregnancy and seizure outcome: observations from EURAP","volume":"57","author":"Tomson","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib187","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.euroneuro.2008.03.001","article-title":"Cannabinoid and opioid modulation of social play behavior in adolescent rats: differential behavioral mechanisms","volume":"18","author":"Trezza","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib188","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.tips.2010.06.008","article-title":"The pleasures of play: pharmacological insights into social reward mechanisms","volume":"31","author":"Trezza","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib189","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neures.2006.10.018","article-title":"Abnormality of circadian rhythm accompanied by an increase in frontal cortex serotonin in animal model of autism","volume":"57","author":"Tsujino","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib190","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.taap.2010.08.001","article-title":"Epigenetic modifications in valproic acid-induced teratogenesis","volume":"248","author":"Tung","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib191","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1479-828X.2011.01359.x","article-title":"The prescribing of antiepileptic drugs for pregnant Australian women","volume":"52","author":"Vajda","year":"2012","journal-title":"Aust. N. Z. J. Obstet. Gynaecol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib192","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/978-3-662-45758-0_268","article-title":"What the laboratory rat has taught us about social play behavior: role in behavioral development and neural mechanisms","volume":"16","author":"Vanderschuren","year":"2014","journal-title":"Curr Top Behav Neurosci"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib193","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0149-7634(96)00020-6","article-title":"The neurobiology of social play behavior in rats","volume":"21","author":"Vanderschuren","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib194","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neubiorev.2016.07.025","article-title":"The neurobiology of social play and its rewarding value in rats","volume":"70","author":"Vanderschuren","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019881","article-title":"What is new for an old molecule? Systematic review and recommendations on the use of resveratrol","volume":"6","author":"Vang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib196","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/YCO.0000000000000133","article-title":"An update on anxiety in youth with autism spectrum disorders","volume":"28","author":"Vasa","year":"2015","journal-title":"Curr. Opin. Psychiatr."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib197","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s12916-017-0845-1","article-title":"Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes","volume":"15","author":"Veroniki","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib198","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1212\/01.WNL.0000154514.82948.69","article-title":"Neuropsychological effects of exposure to anticonvulsant medication in utero","volume":"64","author":"Vinten","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib199","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00007691-198409000-00003","article-title":"Valproic acid in breast milk: how much is really there?","volume":"6","author":"von Unruh","year":"1984","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib200","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.tins.2017.04.005","article-title":"Endocannabinoid signaling in the control of social behavior","volume":"40","author":"Wei","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib201","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresbull.2014.08.001","article-title":"D-Cycloserine ameliorates social alterations that result from prenatal exposure to valproic acid","volume":"108","author":"Wellmann","year":"2014","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib202","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann. Epidemiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib203","doi-asserted-by":"crossref","first-page":"k1609","DOI":"10.1136\/bmj.k1609","article-title":"Dangers of valproate in pregnancy","volume":"361","author":"Wieck","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib204","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00737-007-0175-y","article-title":"A survey of antiepileptic prescribing to women of childbearing potential in psychiatry","volume":"10","author":"Wieck","year":"2007","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib205","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1469-8749.1997.tb07500.x","article-title":"A male with fetal valproate syndrome and autism","volume":"39","author":"Williams","year":"1997","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib206","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1469-8749.2001.tb00188.x","article-title":"Fetal valproate syndrome and autism: additional evidence of an association","volume":"43","author":"Williams","year":"2001","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib207","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/10408440591007403","article-title":"Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin--developmental effects of valproic acid","volume":"35","author":"Wiltse","year":"2005","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib208","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/jmg.24.11.692","article-title":"Fetal valproate syndrome: is there a recognisable phenotype?","volume":"24","author":"Winter","year":"1987","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib209","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/epi.13007","article-title":"Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy","volume":"56","author":"Wood","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib210","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19092840","article-title":"Deep brain stimulation modified autism-like deficits via the serotonin system in a valproic acid-induced rat model","volume":"19","author":"Wu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib211","article-title":"Automated three-chambered social approach task for mice","volume":"8","author":"Yang","year":"2011","journal-title":"Curr Protoc Neurosci Chapter"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib212","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.biopsych.2011.12.029","article-title":"Optogenetic insights into social behavior function","volume":"71","author":"Yizhar","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2018.12.024_bib213","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10571-009-9438-7","article-title":"Ascorbic acid reverses valproic acid-induced inhibition of hoxa2 and maintains glutathione homeostasis in mouse embryos in culture","volume":"30","author":"Zhang","year":"2010","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2018.12.024_bib214","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1242\/dev.120.9.2431","article-title":"Ectopic Hoxa-1 induces rhombomere transformation in mouse hindbrain","volume":"120","author":"Zhang","year":"1994","journal-title":"Development"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818309134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818309134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T06:56:52Z","timestamp":1758437812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818309134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":214,"alternative-id":["S0028390818309134"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.12.024","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prenatal valproate in rodents as a tool to understand the neural underpinnings of social dysfunctions in autism spectrum disorder","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.12.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107477"}}